This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To test whether a newly developed gene therapy (using a recombinant adenoviral vector expressing a beta cell growth factor, betacellulin) can cure diabetes in rhesus macaques by the regeneration of insulin-producing beta- like cells. Success with this gene therapy in the diabetic rhesus monkey may indicate a potential application of this gene therapy to human type 1 diabetes. The information obtained from this study will be invaluable for the development of methods to cure type 1 diabetes in humans. Project is just getting underway. This research used WNPRC Research Services.
Showing the most recent 10 out of 528 publications